Recruitment of epitope-specific T cell clones with a low-avidity threshold supports efficacy against mutational escape upon re-infectionAdrian Straub, Dirk H. Busch, Simon Grassmann et al.|Immunity|2023Cited by 60
Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through ‘reverse phenotyping’David S. Fischer, Kilian Schober, Meshal Ansari et al.|Nature Communications|2021Cited by 42
Recruitment of highly cytotoxic CD8+ T cell receptors in mild SARS-CoV-2 infectionK Wagner, Dirk H. Busch, Stefan Holdenrieder et al.|Cell Reports|2021Cited by 42
CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patientsSimone Weber, Dirk H. Busch, Victoria Kehl et al.|PLoS ONE|2022Cited by 35
Signatures of recent activation identify a circulating T cell compartment containing tumor-specific antigen receptors with high avidityAnna Purcarea, Kilian Schober, Sebastian Jarosch et al.|Science Immunology|2022Cited by 30